Carole Ho, Chief Medical Officer at Denali Therapeutics Inc. (DNLI), sold 4,189 shares at $17.29 ($73K) on 2024-02-13, disclosed to the SEC on 2024-02-15.
Scheduled sale ($73k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.29 | 2,784 | $48K | 65.8% |
| 2 | $17.79 | 1,405 | $25K | 34.2% |
| Total | $17.46 avg | 4,189 | $73K | 100% |
| Filing → |
| DNLI | SELL | 2024-08-22 | $1.1M | — | Filing → |
| DNLI | SELL | 2024-08-15 | $107K | — | Filing → |
| DNLI | SELL | 2024-01-12 | $178K | — | Filing → |